Antacid
NDC Package 53807-151-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Antacid is a medication used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. Marketed by Rij Pharmaceutical Corporation, this product is identified by NDC 53807-151 and is authorized under FDA application part332.

Identification & Billing

NDC Package Code
53807-151-12
Package Description
355 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
53807015112
RxNorm Crosswalk
  • RxCUI: 307750 - aluminum hydroxide 225 MG / magnesium hydroxide 200 MG / simethicone 25 MG in 5 mL Oral Suspension
  • RxCUI: 307750 - aluminum hydroxide 45 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 5 MG/ML Oral Suspension
  • RxCUI: 307750 - aluminum hydroxide 225 MG / magnesium hydroxide 200 MG / simethicone 25 MG per 5 ML Oral Suspension

Clinical Specifications

Proprietary Name
Antacid
Dosage Form
-
Usage Information
This medication is used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

Regulatory & Marketing

Labeler Name
Rij Pharmaceutical Corporation
FDA Application #
part332
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-16-1999
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53807-151-12 identifies a specific commercial package of 355 ml in 1 bottle of Antacid, labeled by Rij Pharmaceutical Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rij Pharmaceutical Corporation on March 16, 1999. The current certification is valid through December 31, 2019.

What are the primary indications for this medication?

This medication is used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

How is this Rij Pharmaceutical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53807015112. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53807-151-12
11-Digit CMS (5-4-2)
53807-0151-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.